Absci and Memorial Sloan Kettering partner to search for cancer drugs using artificial intelligence
alice-photo/Getty Images Artificial Intelligence (AI) The drug development process has yet to be transformed, but some efforts appear more promising than others. On Monday, cancer research giant Memorial Sloan Kettering and life sciences AI pioneer Absci announced a first-of-its-kind partnership to discover six novel cancer therapies using Generative AIpromising to bring new drugs to clinical … 더 읽기